TTRX (Turn Therapeutics Inc. Common Stock) Stock Analysis - SEC Filings

Turn Therapeutics Inc. Common Stock (TTRX) is a publicly traded the market company. As of May 21, 2026, TTRX trades at $4.48 with a market cap of $145.96M and a P/E ratio of -40.28. TTRX moved +0.00% today. Year to date, TTRX is +0.63%; over the trailing twelve months it is flat. Its 52-week range spans $2.57 to $26.50. Rallies surfaces TTRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find TTRX SEC filings?

Rallies organizes TTRX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

TTRX Key Metrics

Key financial metrics for TTRX
MetricValue
Price$4.48
Market Cap$145.96M
P/E Ratio-40.28
EPS$-0.12
Dividend Yield0.00%
52-Week High$26.50
52-Week Low$2.57
Volume6
Avg Volume0
Revenue (TTM)$0
Net Income$-3.19M
Gross Margin0.00%

Latest TTRX News

Recent TTRX Insider Trades

  • Chaudhary Zuraiz bought 2.50K (~$8.75K) on Dec 12, 2025.
  • GOLDEN ARTHUR F bought 9.87K (~$33.95K) on Nov 24, 2025.
  • GOLDEN ARTHUR F bought 20.53K (~$58.93K) on Nov 21, 2025.

TTRX Analyst Consensus

TTRX analyst coverage data. Average price target: $0.00.

Common questions about TTRX

Where can I find TTRX SEC filings?
Rallies organizes TTRX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show TTRX 10-K and 10-Q filings?
Rallies organizes TTRX SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is TTRX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TTRX. It does not provide personalized investment advice.
TTRX

TTRX